# NRC CAL – NOV (SL III)
> **EA-14-115** · CAL · Severity SLIII · Issued 2014-10-08 · Materials Licensees
## Action
- **EA Number:** EA-14-115
- **Licensee:** NOV (SL III)
- **Category:** Materials Licensees
- **Action type:** CAL
- **Severity level:** SLIII
- **Date issued:** 2014-10-08
## Description

On October 8, 2014, the NRC issued a Notice of Violation to Truman Medical Center for a Severity Level III violation of 10 CFR 35.75(a) involving the release of individuals who had been administered unsealed byproduct material. The licensee failed to ensure that a member of the public would not receive an exposure likely to exceed 5 milliSievert (0.5 rem) from the released individual. Specifically, on June 27, 2011, and November 30, 2012, the licensee released individuals who had received I-131 sodium iodide administrations of 70 and 69.3 millicuries, respectively, but the licensee's maximum outpatient release level of 54 millicuries was based on a calculated dose of 5 milliSievert (0.5 rem) to any other individual.

## Source
- [Full enforcement letter (PDF)](https://www.nrc.gov/docs/ML1428/ML14283A577.pdf)
- [NRC Materials Licensees index](https://www.nrc.gov/reading-rm/doc-collections/enforcement/actions/materials/)
---
*MORVS · CC0 1.0*